Neil Singla

Neil Singla

Chief Tech/Sci/R&D Officer at LATIGO BIOTHERAPEUTICS, INC.

Net worth: - $ as of 31/08/2026

54 year
Commercial Services
Consumer Services
Health Technology

Profile

Dr. Neil Singla, MD, is a Chief Medical Officer at Latigo Biotherapeutics, Inc. He is on the Board of Directors at Evolution Research Group LLC.
Dr. Singla was previously employed as a Chairman-Clinical Trials Shared Interest Group by American Pain Society, a Chairman-Clinical Trials Special Interest Group by International Association for the Study of Pain, and a Chief Executive & Scientific Officer by Lotus Clinical Research LLC.
He received his undergraduate degree from the University of Akron and a doctorate degree from Northeast Ohio Medical University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
07/08/2026 0 ( -.--% ) - $ 31/08/2026

Neil Singla active positions

CompaniesPositionStart
LATIGO BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/04/2024
Director/Board Member -

Former positions of Neil Singla

CompaniesPositionEnd
Chief Executive Officer 01/03/2024
Corporate Officer/Principal 01/11/2019
Corporate Officer/Principal 01/11/2019
See the detail of Neil Singla's experience

Training of Neil Singla

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

31

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Health Technology